Drugs and the FDA: Safety, Efficacy, and the Public’s Trust

＂The tension between the drugs patients need & what is necessary to demonstrate safety & efficacy; a story of hope in justifiably desperate patients vs. the time it takes to prove drugs actually work＂--]cProvided by publisher.

Mikkael A. Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and former Chair of the Oncologic Drugs Advisory Committee of the FDA. A regular contributor to the Well section of the New York Times, he is the author of When Blood Breaks Down: Life Lessons from Leukemia (MIT Press).